Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

All Wales Medicines Strategy Group recommends Trulicity for adults with type 2 diabetes

bs_subtitle

More than 180,000 people in Wales currently live with diabetes, with a further 70,000 people living with undiagnosed type 2 diabetes. Dulaglutide is licenced for the treatment of adults with type 2 mellitus to improve glyxaemic control in combination with other medication, including insulin, when other options including in conjunction with exercise and diet, have failed to work. Professor Steve Bain, Assistant Medical Director for Research and Development for ABM University Health Board and Clinical Lead for Diabetes Research Network, Wales, said: “The recommendation of Trulicity by the All Wales Medicine Strategy Group is good news as there is now

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy